Integrating machine learning, bioinformatics and experimental verification to identify a novel prognostic marker associated with tumor immune microenvironment in head and neck squamous carcinoma
机构:[1]Department of Otolaryngology, Longgang Otolaryngology hospital &[2] Shenzhen Key Laboratory of Otolaryngology, Shenzhen Institute of Otolaryngology, Shenzhen, Guangdong, China.[2]Department of Otolaryngology, The Second People's Hospital of Yibin, Yibin, Sichuan, China.
Shenzhen Innovation of Science and Technology Commission
(No. JCYJ20230807091702005, JCYJ20210324132407019,
LGKCYLWS2022002); Shenzhen Key Medical Discipline
Construction Fund (No. SZXK039); Longgang Medical Discipline
Construction Fund (Key Medica Discipline in Longgang District).
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2025]版:
大类|2 区医学
小类|2 区免疫学
最新[2025]版:
大类|2 区医学
小类|2 区免疫学
第一作者:
第一作者机构:[1]Department of Otolaryngology, Longgang Otolaryngology hospital &
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Zeng Xiaoxia,Yang Dunhui,Zhang Jin,et al.Integrating machine learning, bioinformatics and experimental verification to identify a novel prognostic marker associated with tumor immune microenvironment in head and neck squamous carcinoma[J].Frontiers In Immunology.2024,15:1501486.doi:10.3389/fimmu.2024.1501486.
APA:
Zeng Xiaoxia,Yang Dunhui,Zhang Jin,Li Kang,Wang Xijia...&Zhang Peng.(2024).Integrating machine learning, bioinformatics and experimental verification to identify a novel prognostic marker associated with tumor immune microenvironment in head and neck squamous carcinoma.Frontiers In Immunology,15,
MLA:
Zeng Xiaoxia,et al."Integrating machine learning, bioinformatics and experimental verification to identify a novel prognostic marker associated with tumor immune microenvironment in head and neck squamous carcinoma".Frontiers In Immunology 15.(2024):1501486